3 studies found for:    16684987 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)
Condition: Medullary Thyroid Carcinoma
Interventions: Drug: Velcade;   Drug: Vandetanib
2 Recruiting A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin
Condition: Thyroid Neoplasm
Interventions: Drug: Valproic Acid;   Drug: Liothyronine Sodium
3 Recruiting A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC)
Conditions: Solid Tumor;   Anaplastic Thyroid Cancer
Interventions: Drug: Crolibulin;   Drug: Cisplatin

Indicates status has not been verified in more than two years